Moderna struggles with vaccine ramp-up, cuts 2021 sales
Moderna Inc (MRNA.O) on Thursday slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world ...
Pfizer epilepsy drug prices were ‘unfairly high,’ review finds
Britain’s competition watchdog is sticking with its view that Pfizer (PFE.N) and Flynn Pharma broke the law by charging the country’s public health service “unfairly high” prices ...
FDA approves Keytruda for early breast cancer treatment
Merck & Co Inc said on Tuesday that the US Food and Drug Administration approved its immunotherapy Keytruda as a treatment for an early form of a tough-to-treat breast cancer ...
BioNTech strengthens cancer therapy expertise with US acquisition
BioNTech said it was acquiring a production site and a research and development platform from a subsidiary of US biotech company Gilead (GILD.O) to expand its footprint in north ...